Clinical Trial Update: Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia [NA]

View source ↗

Summary

Clinical trial update reporting that metformin reduced relapse rate in patients with B-cell precursor, Ph-negative acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Hospital General de Mexico | Conditions: Acute Lymphoblastic Leukemia | NA | Status: COMPLETED